Target
Glutaminyl-peptide cyclotransferase
Ligand
BDBM435095
Substrate
n/a
Meas. Tech.
QC Inhibition Assay
Ki
114±n/a nM
Citation
 Chen, CShih, CChen, CWang, HHuang, K Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease US Patent  US10584120 Publication Date 3/10/2020 
Target
Name:
Glutaminyl-peptide cyclotransferase
Synonyms:
Glutaminyl Cyclase | Glutaminyl cyclase (QC) | Glutaminyl-peptide cyclotransferase | Glutaminyl-peptide cyclotransferase precursor (QC) | Glutaminyl-tRNA cyclotransferase | Glutamyl cyclase (QC) | QPCT | QPCT_HUMAN
Type:
Enzyme
Mol. Mass.:
40877.05
Organism:
Homo sapiens (Human)
Description:
Q16769
Residue:
361
Sequence:
MAGGRHRRVVGTLHLLLLVAALPWASRGVSPSASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL
  
Inhibitor
Name:
BDBM435095
Synonyms:
US10584120, Compound 26
Type:
Small organic molecule
Emp. Form.:
C21H14F4N4OS
Mol. Mass.:
446.421
SMILES:
Fc1cc(ccc1C1CNC(=O)N1c1ccc2[nH]cnc2c1)-c1csc(c1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: